Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China
- PMID: 31994742
- PMCID: PMC7167192
- DOI: 10.1002/jmv.25689
Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China
Abstract
To help health workers and the public recognize and deal with the 2019 novel coronavirus (2019-nCoV) quickly, effectively, and calmly with an updated understanding. A comprehensive search from Chinese and worldwide official websites and announcements was performed between 1 December 2019 and 9:30 am 26 January 2020 (Beijing time). A latest summary of 2019-nCoV and the current outbreak was drawn. Up to 24 pm, 25 January 2020, a total of 1975 cases of 2019-nCoV infection were confirmed in mainland China with a total of 56 deaths having occurred. The latest mortality was approximately 2.84% with a total of 2684 cases still suspected. The China National Health Commission reported the details of the first 17 deaths up to 24 pm, 22 January 2020. The deaths included 13 males and 4 females. The median age of the people who died was 75 (range 48-89) years. Fever (64.7%) and cough (52.9%) were the most common first symptoms among those who died. The median number of days from the occurence of the first symptom to death was 14.0 (range 6-41) days, and it tended to be shorter among people aged 70 years or more (11.5 [range 6-19] days) than those aged less than 70 years (20 [range 10-41] days; P = .033). The 2019-nCoV infection is spreading and its incidence is increasing nationwide. The first deaths occurred mostly in elderly people, among whom the disease might progress faster. The public should still be cautious in dealing with the virus and pay more attention to protecting the elderly people from the virus.
Keywords: coronavirus; epidemiology; infection.
© 2020 Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
Comment in
-
Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.Travel Med Infect Dis. 2020 Jul-Aug;36:101625. doi: 10.1016/j.tmaid.2020.101625. Epub 2020 Mar 14. Travel Med Infect Dis. 2020. PMID: 32184131 Free PMC article.
-
The role of masks and respirator protection against SARS-CoV-2.Infect Control Hosp Epidemiol. 2020 Jun;41(6):746-747. doi: 10.1017/ice.2020.83. Infect Control Hosp Epidemiol. 2020. PMID: 32192550 Free PMC article. No abstract available.
Similar articles
-
Coronavirus 2019-nCoV: A brief perspective from the front line.J Infect. 2020 Apr;80(4):373-377. doi: 10.1016/j.jinf.2020.02.010. Epub 2020 Feb 25. J Infect. 2020. PMID: 32109444 Free PMC article. Review.
-
Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak.Res Social Adm Pharm. 2020 Apr;16(4):583-586. doi: 10.1016/j.sapharm.2020.02.003. Epub 2020 Feb 12. Res Social Adm Pharm. 2020. PMID: 32081569 Free PMC article.
-
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31. Lancet. 2020. PMID: 32014114 Free PMC article.
-
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. Zhonghua Liu Xing Bing Xue Za Zhi. 2020. PMID: 32064853 Chinese.
-
The Novel Coronavirus: A Bird's Eye View.Int J Occup Environ Med. 2020 Apr;11(2):65-71. doi: 10.15171/ijoem.2020.1921. Epub 2020 Feb 5. Int J Occup Environ Med. 2020. PMID: 32020915 Free PMC article. Review.
Cited by
-
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.Phytother Res. 2021 Aug;35(8):4258-4283. doi: 10.1002/ptr.7092. Epub 2021 Mar 30. Phytother Res. 2021. PMID: 33786876 Free PMC article. Review.
-
D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis.Front Public Health. 2020 Aug 4;8:432. doi: 10.3389/fpubh.2020.00432. eCollection 2020. Front Public Health. 2020. PMID: 32903841 Free PMC article.
-
Review of COVID-19 Treatment.J Res Pharm Pract. 2021 Jan 11;9(4):169-174. doi: 10.4103/jrpp.JRPP_20_72. eCollection 2020 Oct-Dec. J Res Pharm Pract. 2021. PMID: 33912498 Free PMC article. Review.
-
The impact of asymptomatic individuals on the strength of public health interventions to prevent the second outbreak of COVID-19.Nonlinear Dyn. 2020;101(3):2003-2012. doi: 10.1007/s11071-020-05736-x. Epub 2020 Jun 14. Nonlinear Dyn. 2020. PMID: 32836800 Free PMC article.
-
ACE2-based decoy receptors for SARS coronavirus 2.Proteins. 2021 Sep;89(9):1065-1078. doi: 10.1002/prot.26140. Epub 2021 May 18. Proteins. 2021. PMID: 33973262 Free PMC article. Review.
References
-
- Wuhan Municipal Health Commission's briefing on the pneumonia epidemic situation. Released on 31 December 2019 (in Chinese). Available at http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
-
- XINHUANET . New‐type coronavirus causes pneumonia in Wuhan: expert. Released on 9 January 2020. Available at http://www.xinhuanet.com/english/2020-01/09/c_138690570.htm
-
- WHO . Coronavirus. Accessed 20 January 2020. Available at https://www.who.int/health-topics/coronavirus
-
- National Health Commission's briefing on the pneumonia epidemic situation. Released on 26 January 2020 (in Chinese). Available at http://www.nhc.gov.cn/yjb/s7860/202001/9614b05a8cac4ffabac10c4502fe517c....
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources